ResMed has been de-rated from 30x to under 21x earnings despite 17% EPS growth, driven by narrative rather than fundamentals.
THE Terminally Ill Adults Bill returns for another second reading in the Commons today. But the Equality Impact Assessment (EQIA) is dangerously poor.Procedurally, the second reading is usually ...
Usually in Tech In Plain Sight, we talk about technology you probably see every day, even if you don’t notice it. But we hope ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results